The Fourth Revolution: Is Industry 4.0 Changing Manufacturers’ Skill Sets for the Better?

 

In this episode of The Fourth Revolution by Bartell, Pettibone President and CEO Barbara Philibert went into detail on that, when it comes to Industry 4.0, the key to optimizing processes and performance in a global economy is data. “What a universal language data has become,” she said as she recalled a meeting in China where data helped bridge the language barrier.

Growing up in rural Iowa, manufacturing was a simple affair, Philibert said. Reflecting on her 30-year career in the industry, she noted that manufacturing has evolved into a complex and global behemoth, which present benefits and challenges.

The production floor has also undergone a data-influenced transformation. Decades ago, when Philibert would venture onto the job site, the production leads would guide her through the site, physically showing her manufacturing progress. Now they’re using tablet computers to show her how they make it and the data to go along with it.

These small and large shifts toward data usage on the manufacturing floor have created a shift in the workforce. Workers are having to adjust their skill sets to match a more analytical future for the floor, whether that means software usage or data comprehension.

Is the industry ready for this change? Philibert gives her take on the podcast, breaking down how the combination of a generation of workers aging out of the industry and a lack of information around careers in manufacturing is setting the stage for a lack of skilled workers and forcing companies to address the changing standard for manufacturing skills.

The CEO sees how younger employees in manufacturing are natural at using technology, and she advocated for high schools and guidance counselors to encourage more young people to seek long-term careers in the industry. Faced with a current skilled labor shortage, she has some advice for manufacturing companies: “Reach out to the community colleges, reach out to your schools… invite [them] in to show them what we can do.”

For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @AECMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More